NCT04375085View on ClinicalTrials.gov

DESyne X2 Post Market Follow-up Study

NATerminatedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

December 28, 2021

Study Completion Date

December 28, 2021

Conditions
Coronary Artery Disease
Interventions
DEVICE

Percutaneous Coronary Intervention

Percutaneous Coronary Intervention

Trial Locations (3)

Unknown

Kwong Wah Hospital, Hong Kong

Queen Elizabeth Hospital, Hong Kong

Tseung Kwan O Hospital, Hong Kong

Sponsors
All Listed Sponsors
lead

Elixir Medical Corporation

INDUSTRY

NCT04375085 - DESyne X2 Post Market Follow-up Study | Biotech Hunter | Biotech Hunter